Evolution of human immunodeficiency virus type 1 coreceptor usage during antiretroviral Therapy: a Bayesian approach.
Kitchen
Christina M R
CM
Department of Biostatistics, UCLA School of Public Health, Los Angeles, CA 90095-1772. cr@ucla.edu
Philpott
Sean
S
Burger
Harold
H
Weiser
Barbara
B
Anastos
Kathryn
K
Suchard
Marc A
MA
D023241:Antiretroviral Therapy, Highly Active; D001499:Bayes Theorem; D019143:Evolution, Molecular; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D010802:Phylogeny; D019713:Receptors, CCR5 / Q000378:metabolism*; D019718:Receptors, CXCR4 / Q000378:metabolism*; D017422:Sequence Analysis, DNA
D019713:Receptors, CCR5; D019718:Receptors, CXCR4